Business
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results GlobeNewswire May 02, 2024 Reported $420.5 million in cash resources as of March 31, 2024, which when combined wit
GlobeNewswire
May 02, 2024
Reported $420.5 million in cash resources as of March 31, 2024, which when combined with certain anticipated regulatory milestone payments provides projected cash runway into 2H 2027Completion of rolling biologics license application (BLA) filing with the U.S.
Related
Share this page
